Daniel Halpérin

1.5k total citations
44 papers, 1.0k citations indexed

About

Daniel Halpérin is a scholar working on Molecular Biology, Genetics and Epidemiology. According to data from OpenAlex, Daniel Halpérin has authored 44 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 7 papers in Genetics and 6 papers in Epidemiology. Recurrent topics in Daniel Halpérin's work include Ion channel regulation and function (5 papers), Hereditary Neurological Disorders (3 papers) and CRISPR and Genetic Engineering (3 papers). Daniel Halpérin is often cited by papers focused on Ion channel regulation and function (5 papers), Hereditary Neurological Disorders (3 papers) and CRISPR and Genetic Engineering (3 papers). Daniel Halpérin collaborates with scholars based in Israel, United States and Switzerland. Daniel Halpérin's co-authors include Peter Tontonoz, MH Freedman, Kye Won Park, Pierre Wacker, Marinette Wyss, Paul Bouvier, Matti Aapro, G Lacourt, Ohad S. Birk and Yonatan Perez and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Daniel Halpérin

41 papers receiving 975 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Halpérin Israel 18 327 196 160 144 142 44 1.0k
Bei Liu China 19 290 0.9× 30 0.2× 197 1.2× 155 1.1× 32 0.2× 103 1.0k
Christoph Zenzmaier Austria 23 569 1.7× 112 0.6× 49 0.3× 49 0.3× 48 0.3× 48 1.3k
Marilyn E. Miller United States 18 103 0.3× 131 0.7× 274 1.7× 108 0.8× 15 0.1× 41 976
Ken Muse United States 21 138 0.4× 302 1.5× 66 0.4× 35 0.2× 23 0.2× 36 1.5k
Ronny Baber Germany 16 144 0.4× 136 0.7× 48 0.3× 34 0.2× 40 0.3× 56 811
Benedetta Izzi Belgium 23 722 2.2× 50 0.3× 177 1.1× 51 0.4× 87 0.6× 49 1.4k
Carly E. Herbison Australia 15 111 0.3× 73 0.4× 173 1.1× 113 0.8× 70 0.5× 23 695
Licínio Manco Portugal 18 328 1.0× 349 1.8× 114 0.7× 131 0.9× 64 0.5× 68 1.1k
Samim Özen Türkiye 20 298 0.9× 140 0.7× 40 0.3× 59 0.4× 67 0.5× 104 1.2k
P.A.H. van Noord Netherlands 23 445 1.4× 224 1.1× 29 0.2× 30 0.2× 24 0.2× 36 1.9k

Countries citing papers authored by Daniel Halpérin

Since Specialization
Citations

This map shows the geographic impact of Daniel Halpérin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Halpérin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Halpérin more than expected).

Fields of papers citing papers by Daniel Halpérin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Halpérin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Halpérin. The network helps show where Daniel Halpérin may publish in the future.

Co-authorship network of co-authors of Daniel Halpérin

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Halpérin. A scholar is included among the top collaborators of Daniel Halpérin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Halpérin. Daniel Halpérin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aberg, Kristoffer C., Daniel Halpérin, Genela Morris, et al.. (2025). Rate and noise in human amygdala drive increased exploration in aversive learning. Nature. 646(8086). 883–892.
2.
Provenzano, David, Joseph Atallah, Binit Shah, et al.. (2025). Assessment of real-world, prospective outcomes in patients treated with lumbar radiofrequency ablation for chronic pain (RAPID). Interventional Pain Medicine. 4(2). 100576–100576.
3.
Halpérin, Daniel, et al.. (2025). Aversive generalization in human amygdala neurons. Current Biology. 35(5). 1137–1144.e3. 4 indexed citations
4.
Yogev, Yuval, Moshe Schaffer, Ohad Wormser, et al.. (2024). A role of BPTF in viral oncogenicity delineated through studies of heritable Kaposi sarcoma. Journal of Medical Virology. 96(2). e29436–e29436. 1 indexed citations
5.
Yogev, Yuval, Ohad Wormser, Daniel Halpérin, et al.. (2024). VARista: a free web platform for streamlined whole-genome variant analysis across T2T, hg38, and hg19. Human Genetics. 143(5). 695–701. 5 indexed citations
6.
Wormser, Ohad, Yonatan Perez, Libe Gradstein, et al.. (2023). IHH enhancer variant within neighboring NHEJ1 intron causes microphthalmia anophthalmia and coloboma. npj Genomic Medicine. 8(1). 22–22. 1 indexed citations
7.
Halpérin, Daniel, Yuval Yogev, Ohad Wormser, et al.. (2023). SMARCA4 mutation causes human otosclerosis and a similar phenotype in mice. Journal of Medical Genetics. 61(2). 117–124.
8.
Halpérin, Daniel, Yuval Yogev, Ohad Wormser, et al.. (2022). A syndrome of severe intellectual disability, hypotonia, failure to thrive, dysmorphism, and thinning of corpus callosum maps to chromosome 7q21.13‐q21.3. Clinical Genetics. 102(2). 123–129. 2 indexed citations
9.
Halpérin, Daniel, Rotem Kadir, Ohad Wormser, et al.. (2021). CDH2 mutation affecting N-cadherin function causes attention-deficit hyperactivity disorder in humans and mice. Nature Communications. 12(1). 6187–6187. 23 indexed citations
10.
Halpérin, Daniel, Ohad Wormser, Yuval Yogev, et al.. (2020). Phenotypic variability and mutation hotspot in COX15‐related Leigh syndrome. American Journal of Medical Genetics Part A. 182(6). 1506–1512. 9 indexed citations
11.
Halpérin, Daniel, et al.. (2020). Novel MTMR2 mutation causing severe Charcot-Marie-Tooth type 4B1 disease: a case report. Neurogenetics. 21(4). 301–304. 2 indexed citations
12.
Yogev, Yuval, Lior Zeller, Raz Zarivach, et al.. (2019). Hyperuricemia and gout caused by missense mutation in d-lactate dehydrogenase. Journal of Clinical Investigation. 129(12). 5163–5168. 29 indexed citations
13.
Halpérin, Daniel, Yuval Yogev, Ohad Wormser, et al.. (2019). A novel SLC12A1 mutation in Bedouin kindred with antenatal Bartter syndrome type I. Annals of Human Genetics. 83(5). 361–366. 5 indexed citations
14.
Halpérin, Daniel, Rotem Kadir, Yonatan Perez, et al.. (2018). SEC31A mutation affects ER homeostasis, causing a neurological syndrome. Journal of Medical Genetics. 56(3). 139–148. 27 indexed citations
15.
Flusser, Hagit, Daniel Halpérin, Rotem Kadir, et al.. (2018). Novel SBF1 splice‐site null mutation broadens the clinical spectrum of Charcot‐Marie‐Tooth type 4B3 disease. Clinical Genetics. 94(5). 473–479. 11 indexed citations
16.
Munteanu, Daniela, Ohad Etzion, Gil Ben Yakov, et al.. (2017). Efficacy and safety of sequential versus quadruple therapy as second-line treatment for helicobacter pylori infection—A randomized controlled trial. PLoS ONE. 12(9). e0183302–e0183302. 18 indexed citations
17.
Zhang, Qiongyi, Muhammad Khairul Ramlee, Reinhard Brunmeir, et al.. (2012). Dynamic and distinct histone modifications modulate the expression of key adipogenesis regulatory genes. Cell Cycle. 11(23). 4310–4322. 63 indexed citations
18.
Halpérin, Daniel, Calvin Pan, Aldons J. Lusis, & Peter Tontonoz. (2012). Vestigial-like 3 is an inhibitor of adipocyte differentiation. Journal of Lipid Research. 54(2). 473–481. 43 indexed citations
19.
Weiser, Mark, Avi Reichenberg, Nomi Werbeloff, et al.. (2009). Increased number of offspring in first degree relatives of psychotic individuals: a partial explanation for the persistence of psychotic illnesses. Acta Psychiatrica Scandinavica. 119(6). 466–471. 6 indexed citations
20.
Gervaix, Alain, et al.. (1995). Cefetamet Pivoxil in the Treatment of Pharyngotonsillitis Due to Group A Beta-Hemolytic Streptococci: Preliminary Report. Journal of Chemotherapy. 7(sup1). 21–24. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bei Liu Breakdown of academic impact, for papers by Christoph Zenzmaier Breakdown of academic impact, for papers by Marilyn E. Miller Breakdown of academic impact, for papers by Ken Muse Breakdown of academic impact, for papers by Ronny Baber Breakdown of academic impact, for papers by Benedetta Izzi Breakdown of academic impact, for papers by Carly E. Herbison Breakdown of academic impact, for papers by Licínio Manco Breakdown of academic impact, for papers by Samim Özen Breakdown of academic impact, for papers by P.A.H. van Noord
Rankless by CCL
2026